<?xml version="1.0" encoding="UTF-8"?>
<p id="p0160">Proteases PL
 <sup>pro</sup> and 3CL
 <sup>pro</sup> mediate the proteolytic cleavage of polypeptides produced by Î²-coronavirus SARS after genome transcription, thus generating other proteins. The 3CL
 <sup>pro</sup>, known as Nsp5, cleavages several non-structural proteins of importance for viral replication and the maturation of Nsps, which is essential in the life cycle of the virus. Therefore, it is an attractive biological target for that has been inhibited 
 <italic>in-silico</italic> by several antiviral, anti-inflammatory and anti-hypertensive drugs from the database ZINC (FDA).
 <xref rid="b0025" ref-type="bibr">
  <sup>5</sup>
 </xref> In addition, docking and molecular dynamic studies conducted by Qamar et al.
 <xref rid="b0385" ref-type="bibr">
  <sup>77</sup>
 </xref> showed that non-toxic natural products formed strong bonds with SARS-CoV-2 catalytic dyad Cis145-His41 of 3CL
 <sup>pro</sup>.
</p>
